Navigation Links
United Therapeutics Reports Third Quarter 2007 Financial Results
Date:11/1/2007

7 5,622

Depreciation and amortization 865 724

Stock option expense 8,040 4,837

EBITDASO $ 26,637 $ 19,661

EBITDASO earnings per share (1):

Basic $ 1.26 $ 0.85

Diluted $ 1.19 $ 0.79

(1) Calculated by dividing pro forma net income from above by weighted average shares outstanding, as reported below.

Conference Call

United Therapeutics will host a one hour teleconference on Thursday, November 1, 2007, at 9:00 a.m. Eastern Time. The teleconference is accessible by dialing 1-800-603-1777, with international callers dialing 1-706-679-8129. A rebroadcast of the teleconference will be available for one week following the teleconference by dialing 1-800-642-1687, with international callers dialing 1-706-645-9291, and using access code 20811764.

This teleconference is also being web cast and can be accessed via United Therapeutics' website at http://ir.unither.com/eventdetail.cfm?eventid=45704.

About United Therapeutics

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Non-GAAP Financial Information

This press release contains certain financial measures that do not comply with GAAP, which measures supplement our financial results prepared in accordance with GAAP.

We believe that the presentation of pro forma net income, a non-GAAP measure, is meaningful to investors, when used in conjunction with United Therapeutics' financial statements, because it aids them in comparing our financial results for such periods taking into account the effect
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Inacom Education earns Wisconsin membership in United Training
2. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
3. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
4. Sonic Foundry reports GAAP loss as Q2 revenues rise
5. Fiserv reports $113.5 million in Q1 profit
6. Third Wave reports net loss of $18.9M for 2006
7. Musicnotes reports 45 percent growth in 2006
8. Sonic Foundry reports net loss, higher revenue
9. Sonic Foundry reports first cash-positive quarter
10. Merge Healthcare reports $10.8M net loss in Q3
11. Third Wave reports $5.2M third quarter loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...wswire/ -- The Eniva Research Group has,released r...Linus Pauling,Micronutrient Research Institute at ...va Health Supplement VIBE(R) possessed DNA protect...third party testing was,performed as part of an on...hanisms by which the Eniva VIBE nutraceutical impa...
(Date:7/3/2008)...wire/ - OncoGenex Technologies Inc. and Isis,Pharm...that the companies,have amended their agreement an...ts lead cancer drug OGX-011. Under the amended agr...ture development activities,costs and partnering ...be,responsible for funding 35% of development cost...
(Date:7/3/2008)...RNewswire-FirstCall/ -- AMDL, Inc. (Amex:,ADL), a ...tered in Tustin,Ca., with operations in Shenzhen,... released its investor presentation which is avail...://www.amdl.com ., About AMDL:, AMDL, Inc. is a ...ny is,headquartered in Tustin, California with ope...
(Date:7/2/2008)...ing Stent to Demonstrate Superiority Over,Market-L...United States for Treatment of Co.../- Abbott today,announced t...proved the,XIENCE(TM) V Everolimus Eluting Coronar...y disease. XIENCE V is the only drug eluting stent...
Breaking Biology Technology:Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties 2OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5
...s. - Two of the largest U.S.-based multi-national...Milwaukee County Research Park . , , Johnson Contr...the park, according to Dave Domres, vice president...ers, LLC . , ,Johnson Controls, a Milwaukee-based...lobal manufacturer of automotive systems, plans to...
...es with Google , Yahoo , and MSN have marketer..., ,In recent months, popular search engines have u...ers to target specific ad positions within search ...results; and Yahoo announced a partnership with eB...ting search engines remains uncertain, it,s certai...
...article, we looked at the leading pharmaceutical c...cal market, which for the first time surpassed $6...rt of equation, as another significant market is t...e numbers on the size of the total medical device ... $200 billion in annual revenue in 2005, as the to...
... - Since its inception, Venture Investors has e...at was popularized on the coasts, and it now has a...arly-stage businesses. , ,The Madison-based ventur... from mostly Wisconsin sources for its new Venture... and already is in discussions with several prospe...
Other Biology Technology:Location, location, location: Spots to consider for online ads 2Location, location, location: Spots to consider for online ads 3Location, location, location: Spots to consider for online ads 4Midwest retains dominant role in 2005 world medical device market 2Midwest retains dominant role in 2005 world medical device market 3Midwest retains dominant role in 2005 world medical device market 4Midwest retains dominant role in 2005 world medical device market 5Midwest retains dominant role in 2005 world medical device market 6Midwest retains dominant role in 2005 world medical device market 7Venture Investors looks to fund 20 companies 2Venture Investors looks to fund 20 companies 3
(Date:7/2/2008)... to produce a lot of a substance -- such as a newl...olecules that speed chemical reactions. Many jobs ...one in just the right shape to connect with certai...uch as enzymes in the human body that help us dige... to suit the task at hand. , Chemists have made ...
(Date:7/2/2008)...n . , Metabolomics aims to determine the totalit...e exponents of bioinformatics analyzed data collec...s study in healthy and diabetic mice. In each case...iabetes drug RoziglitazoneTM. Then, more than 800 ...ood plasma sample of a total of forty mice, repres...
(Date:7/2/2008)...ish . , Most of the functions performed by a ce..., which recognise their binding partner by affinit... are many kinds of interactions; however, the most...ctural biology are those which are transient. This... large section of the protein surface- the globula...
(Date:7/2/2008)...its kind, using sophisticated methods to measure b...eight loss program, Weight Watchers, was compared ...d wins in the game of good health. A University of...ences of participants to determine which program h...health benefits. The answer is that both have pros...
Breaking Biology News(10 mins):Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Weight Watchers vs. fitness centers 2Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 3414 1Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU 3414 2Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 1Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 2Linkwell Corporation Runs 24 7 Disinfectant Operations to Support Chinas Earthquake Relief Efforts 20167 3Understanding autumn rain decline in SE Australia 3411 1Understanding autumn rain decline in SE Australia 3411 2TriWest Teaches California Kids About Veterans Sacrifice Courage 20159 1TriWest Teaches California Kids About Veterans Sacrifice Courage 20159 2
...particles weaken the bonding of hip, knee, and oth...shed online in Proceedings of the National Academy...alifornia, San Diego (UCSD) School of Medicine and...trated that titanium implants are safe in large bl...can generate micrometer-sized particles. , "As re...
...overed a fascinating symbiotic relationship betwee...species ?a relationship that potentially sheds lig... higher organisms in defensive mechanisms against ...that a solitary ground-nesting wasp, the European ...tructures within its antennae and that females uti...
...t imaging technology a team from Yale School of Me...nt ,nano-machines, in action. The work, performed ...s, provides new insight into the machinery cells u...lls traffic protein cargos across their outer memb...go internalization is clathrin mediated endocytosi...
...lished in the Journal of Biological Chemistry, sci...to play a purely structural and inert role in cell...cancer. Using antagonists for this molecule, the r...reast cancer cells to chemotherapeutic drug treatm...Week" in the May 27 issue of the Journal of Biolog...
Other Biology News:UCSD medical/bioengineering reseachers show titanium debris satobtage artificial joints 2Symbiotic bacteria protect hunting wasps from fungal infestation 2Researchers develop assay that could be applied to drug screening 2New polysaccharide may help combat multidrug resistance in cancer 2
Mouse monoclonal [2D7/1] to E.coli LPS ( Abpromise for all tested applications). Antigen: Tissue / cell preparation: Escherichia coli J5 cells.
Request Info
Vesicle Associated Membrane Protein (VAMP 1/2)
Human / Porcine Endothelin 1 from AnaSpec
Biology Products: